tiprankstipranks
Voyageur Pharmaceuticals Ltd. (VYYRF)
:VYYRF
US Market
Holding VYYRF?
Track your performance easily

Voyageur Pharmaceuticals (VYYRF) Financial Statements

2 Followers

Voyageur Pharmaceuticals Financial Overview

Voyageur Pharmaceuticals's market cap is currently ―. The company's EPS TTM is $-0.008; its P/E ratio is ―; Voyageur Pharmaceuticals is scheduled to report earnings on March 26, 2025, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Aug 24May 24Feb 24Nov 23Aug 23
Income Statement-
Total Revenue-----
Gross Profit-----
EBIT$ -359.13K$ -561.90K$ -328.95K$ -273.60K$ -130.69K
EBITDA$ -359.13K$ -561.12K$ -328.55K$ -273.05K$ -130.69K
Net Income Common Stockholders$ -359.13K$ -561.90K$ -328.95K$ -273.60K$ -130.69K
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 3.04K$ 13.17K$ 249.75K$ 2.08K$ 1.88K
Total Assets$ 2.33M$ 2.32M$ 2.56M$ 2.16M$ 2.17M
Total Debt$ ―$ ―$ ―$ ―$ ―
Net Debt$ ―$ ―$ ―$ ―$ ―
Total Liabilities$ 1.39M$ 1.08M$ 985.22K$ 727.88K$ 467.67K
Stockholders Equity$ 944.82K$ 1.25M$ 1.58M$ 1.44M$ 1.71M
Cash Flow-
Free Cash Flow$ 154.56K$ -448.01K$ -220.62K-$ -80.30K
Operating Cash Flow$ 172.00K$ -372.36K$ -183.07K-$ -67.48K
Investing Cash Flow$ -17.44K$ -75.65K$ -37.55K-$ -54.74K
Financing Cash Flow$ -412.36K$ 459.09K$ 468.28K-$ -1.13M
Currency in USD

Voyageur Pharmaceuticals Earnings and Revenue History

Voyageur Pharmaceuticals Debt to Assets

Voyageur Pharmaceuticals Cash Flow

Voyageur Pharmaceuticals Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis